ArchivesMagazine - 20 Jul 2017End market signals from Vodafone India and slowing UK to come under microscope 20 July 2017|Week Ahead Issue: 20 Jul 2017 - Page 19 < Will GlaxoSmithKline continue to struggle with asthma product sales? Will Provident turn it around? > Issue: 20 Jul 2017 - Page 19 | Contents Next: Will Provident turn it around? Previous: Will GlaxoSmithKline continue to struggle with asthma product sales? Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Steven Frazer Issue Contents Editor's View Do the rewards compensate for the risks taken? Feature Our Great Ideas are beating the market Three stocks to play the digital healthcare revolution Great Ideas Accesso looks like a prime takeover target Accrol is flush with potential Investment Trusts Looking for opportunities among large companies Larger Companies Are investors focusing on the wrong catalyst for Ryanair’s future growth? Main Feature Searching for small cap value Money Matters The importance of shopping around for your pension Five ways to boost your retirement income News Brexit puts squeeze on consumers and businesses Pressure on Blancco Technology Keep toasting cash-generative Conviviality Yu Group to beat forecasts Weir seeing North American shale recovery Carillion bailed out by HS2 What will McCall do at ITV? Sage to sidestep HMRC’s digital delay EasyJet reveals post-Brexit plans as CEO departs Smaller Companies Thalassa abandons subsidiary sale Monthly sales at Venture Life hit five-year high Arena gets its skates on Sound Energy switches focus to Morocco Gateley offers the full service Story In Numbers WideCells aims to take advantage of lucrative cord blood market Housing market remains resilient Robot workforce on the march Premier zooms higher on Zama find Carillion goes into freefall Under The Bonnet The rapid growth story flying under the radar Week Ahead Will GlaxoSmithKline continue to struggle with asthma product sales? End market signals from Vodafone Will Provident turn it around?